CanSino Biologics, Inc. (CASBF)
4.90
+0.25
(+5.32%)
USD |
OTCM |
Oct 06, 16:00
CanSino Biologics Market Cap : 1.211B for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 1.211B |
| October 05, 2026 | 1.149B |
| October 02, 2026 | 1.149B |
| October 01, 2026 | 1.149B |
| September 30, 2026 | 728.78M |
| September 29, 2026 | 728.78M |
| September 28, 2026 | 728.78M |
| September 25, 2026 | 728.78M |
| September 24, 2026 | 728.78M |
| September 23, 2026 | 728.78M |
| September 22, 2026 | 728.78M |
| September 21, 2026 | 728.78M |
| September 18, 2026 | 728.78M |
| September 17, 2026 | 728.78M |
| September 16, 2026 | 728.78M |
| September 15, 2026 | 1.136B |
| September 14, 2026 | 1.136B |
| September 11, 2026 | 1.136B |
| September 10, 2026 | 1.136B |
| September 09, 2026 | 1.136B |
| September 08, 2026 | 1.136B |
| September 04, 2026 | 1.136B |
| September 03, 2026 | 1.136B |
| September 02, 2026 | 1.136B |
| September 01, 2026 | 1.136B |
| Date | Value |
|---|---|
| August 31, 2026 | 1.136B |
| August 28, 2026 | 1.136B |
| August 27, 2026 | 1.136B |
| August 26, 2026 | 1.122B |
| August 25, 2026 | 963.47M |
| August 24, 2026 | 963.47M |
| August 21, 2026 | 963.47M |
| August 20, 2026 | 963.47M |
| August 19, 2026 | 776.95M |
| August 18, 2026 | 776.95M |
| August 17, 2026 | 776.95M |
| August 14, 2026 | 776.95M |
| August 13, 2026 | 776.95M |
| August 12, 2026 | 776.95M |
| August 11, 2026 | 776.95M |
| August 10, 2026 | 776.95M |
| August 07, 2026 | 776.95M |
| August 06, 2026 | 776.95M |
| August 05, 2026 | 776.95M |
| August 04, 2026 | 776.95M |
| August 03, 2026 | 776.95M |
| July 31, 2026 | 776.95M |
| July 30, 2026 | 776.95M |
| July 29, 2026 | 776.95M |
| July 28, 2026 | 776.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sinovac Biotech Ltd. | 464.94M |
| CASI Pharmaceuticals, Inc. | 2.261M |
| Shanghai Junshi Biosciences Co., Ltd. | 3.437B |
| Ascletis Pharma, Inc. | 1.097B |
| CStone Pharmaceuticals Co. Ltd. | 1.201B |
Market Cap Related Metrics
| PE Ratio | 208.51 |
| PS Ratio | 6.856 |
| Price to Book Value | 1.650 |
| Price | 4.90 |
| Earnings Yield | 0.48% |
| Normalized PE Ratio | 286.55 |